Healthcare - Biotechnology - NASDAQ - US
$ 4.79
-11 %
$ 406 M
Market Cap
-1.95
P/E
BALANCE SHEET
753 M
ASSETS
153 M
LIABILITIES
600 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Verve Therapeutics, Inc.
| Current Assets | 638 M |
| Cash & Short-Term Investments | 624 M |
| Receivables | 5.9 M |
| Other Current Assets | 8.1 M |
| Non-Current Assets | 115 M |
| Long-Term Investments | 0 |
| PP&E | 108 M |
| Other Non-Current Assets | 6.94 M |
| Current Liabilities | 37 M |
| Accounts Payable | 6.64 M |
| Short-Term Debt | 20.4 M |
| Other Current Liabilities | 9.99 M |
| Non-Current Liabilities | 116 M |
| Long-Term Debt | 64.7 M |
| Other Non-Current Liabilities | 51.5 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 206.2 | 115.4 | 64.3 | 9.0 | 3.0 |
| Short Term Investments | 417.8 | 439.4 | 296.1 | 63.1 | 15.8 |
| Receivables | 5.9 | 1.0 | 0 | 0 | 0 |
| Inventory | 0 | 1 | 0 | 0 | 0 |
| Other Current Assets | 8.1 | 7.3 | 13.4 | 1.9 | 0.3 |
| Total Current Assets | 637.9 | 563.2 | 367.1 | 74.0 | 19.1 |
| PP&E | 107.8 | 110.7 | 9.1 | 4.0 | 2.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 4.8 | 5.2 | 0.5 | 0.2 |
| Other Long Term Assets | 6.9 | 0.6 | 2.7 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 752.7 | 679.2 | 384.1 | 78.4 | 21.6 |
| LIABILITIES | |||||
| Accounts Payable | 6.6 | 2.4 | 7.1 | 36 K | 2.4 |
| Short Term Debt | 20.4 | 23.8 | 3.9 | 0 | 0 |
| Other Current Liabilities | 10.0 | 8.9 | 11.0 | 7.2 | 1.1 |
| Total Current Liabilities | 37.0 | 35.1 | 22.0 | 7.3 | 3.6 |
| Long Term Debt | 64.7 | 70.0 | 0 | 125.2 | 35.1 |
| Deferred Tax Income | 0 | 0 | 0 | (125.3) | (35.2) |
| Other Liabilities | 2.9 | 3.2 | 4.7 | 9.7 | 2.5 |
| Total Liabilities | 153.2 | 128.3 | 26.8 | 142.3 | 41.2 |
| EQUITY | |||||
| Common Stock | 82 K | 62 K | 49 K | 3 K | 2 K |
| Retained Earnings | (544.3) | (344.2) | (186.8) | (66.5) | (20.8) |
| Other Accumulative Comprehensive Income/Loss | 0.3 | (0.7) | (0.2) | 8 K | 9 K |
| Total Equity | 599.5 | 550.9 | 357.4 | (63.9) | (19.6) |
| Total Liabilities and Equity | 752.7 | 679.2 | 384.1 | 78.4 | 21.6 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 64.2 | 54.0 | 48.5 | 48.2 | 48.2 |